The trial is tied to a post-marketing commitment that FDA Commissioner Martin Makary put in place last year for all approved ...
In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug ...
By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...
Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, a lackluster result ...
Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...
Pfizer and Valneva have blamed “fewer than anticipated” Lyme disease cases for the failure of their phase 3 trial to hit its ...
Vaccine maker's critics hope for new attorney general to reverse Pam Bondi's hostility to clinical trial whistleblower's ...
The drugmaker is seeking regulatory review for the first new shot to combat the disease in decades.
After shedding expensive commercial infrastructure and pivoting to a partnership model, the company is now positioning its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results